The bill proposes significant amendments to South Dakota's controlled substances schedule, specifically focusing on the classification of opium derivatives, opiates, and hallucinogenic substances. It aims to add a comprehensive list of substances to Schedule I, which are recognized for their high potential for abuse and lack of accepted medical use. Key additions include various fentanyl analogs, synthetic cannabinoids, and hallucinogens such as DMT and LSD. The bill also stipulates that any compounds structurally related to these substances will be classified under Schedule I unless explicitly exempted, thereby broadening the scope of regulation.

In addition to the new classifications, the bill clarifies definitions and chemical structures of the substances being added, ensuring that derivatives or modifications are also included in the controlled substances schedule. It highlights the need to keep the law current with the evolving landscape of drug formulations to address public health concerns related to drug abuse and addiction. The bill also declares an emergency, indicating that these modifications are essential for the immediate preservation of public peace, health, or safety, and will take effect immediately upon passage and approval.

Statutes affected:
Introduced, 01/03/2025: 34-20B-13, 34-20B-14
Enrolled, 02/07/2025: 34-20B-13, 34-20B-14